Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
- PMID: 12453678
- DOI: 10.1016/s0169-409x(02)00160-6
Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings
Abstract
Receptor for Advanced Glycation Endproducts (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules capable of interacting with a broad spectrum of ligands, including advanced glycation endproducts (AGEs), amyloid fibrils, S100/calgranulins and amphoterin. The biology of RAGE is dictated by the accumulation of these ligands at pathologic sites, leading to upregulation of the receptor and sustained RAGE-dependent cell activation eventuating in cellular dysfunction. Although RAGE is not central to the initial pathogenesis of disorders in which it ultimately appears to be involved, such as diabetes, amyloidoses, inflammatory conditions and tumors (each of these conditions leading to accumulation of RAGE ligands), the receptor functions as a progression factor driving cellular dysfunction and exaggerating the host response towards tissue destruction, rather than restitution of homeostasis. These observations suggest that RAGE might represent a therapeutic target in a diverse group of seemingly unrelated disorders linked only by a multiligand receptor with an unusually wide and diverse repertoire of ligands, namely, RAGE.
Copyright 2002 Elsevier Science B.V.
Similar articles
-
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review.
-
The biology of the receptor for advanced glycation end products and its ligands.Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111. doi: 10.1016/s0167-4889(00)00087-2. Biochim Biophys Acta. 2000. PMID: 11108954 Review.
-
RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.Semin Thromb Hemost. 2000;26(5):485-93. doi: 10.1055/s-2000-13204. Semin Thromb Hemost. 2000. PMID: 11129404 Review.
-
RAGE: a multi-ligand receptor unveiling novel insights in health and disease.Curr Med Chem. 2010;17(21):2232-52. doi: 10.2174/092986710791331086. Curr Med Chem. 2010. PMID: 20459381 Review.
-
Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.Front Biosci. 2001 Oct 1;6:D1151-60. doi: 10.2741/schmidt. Front Biosci. 2001. PMID: 11578972 Review.
Cited by
-
S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.Clin Exp Immunol. 2013 Sep;173(3):523-35. doi: 10.1111/cei.12139. Clin Exp Immunol. 2013. PMID: 23682982 Free PMC article.
-
Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats.Evid Based Complement Alternat Med. 2013;2013:983923. doi: 10.1155/2013/983923. Epub 2013 Jan 10. Evid Based Complement Alternat Med. 2013. PMID: 23365614 Free PMC article.
-
Targeting the "Rising DAMP" during a Francisella tularensis Infection.Antimicrob Agents Chemother. 2013 Sep;57(9):4222-4228. doi: 10.1128/AAC.01885-12. Epub 2013 Jun 24. Antimicrob Agents Chemother. 2013. PMID: 23796927 Free PMC article.
-
RAGE signaling in inflammation and arterial aging.Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1403-13. doi: 10.2741/3315. Front Biosci (Landmark Ed). 2009. PMID: 19273137 Free PMC article. Review.
-
Vascular stiffness and increased pulse pressure in the aging cardiovascular system.Cardiol Res Pract. 2011;2011:263585. doi: 10.4061/2011/263585. Epub 2011 Aug 2. Cardiol Res Pract. 2011. PMID: 21845218 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
